Cerenome
€3.45
231
+€0.38+12.38% Friday 18:52
Statistics
Day High
3.45
Day Low
3.45
52W High
28.6
52W Low
1.144
Volume
0
Avg. Volume
51
Mkt Cap
26.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
15OctExpected
Q1 2026
Next
-0.9
-0.85
-0.79
-0.73
Expected EPS
-0.761808
Actual EPS
N/A
Financials
-450.91%Profit Margin
Unprofitable4.51MRevenue
-20.35MNet Income
Analyst Ratings
43.25Average Price Target
The highest estimate is 43.25.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow XMP1.MU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mustang Bio
MBIO
Mkt Cap4.07M
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Fate Therapeutics
FATE
Mkt Cap291.16M
Allogene Therapeutics
ALLO
Mkt Cap697.89M
About
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Show more...
CEO
Marc H. Hedrick
Employees
28
Country
United States
ISIN
US72941H8060
WKN
000A422GY
Listings
0 Comments
Share your thoughts
FAQ
What is Cerenome stock price today?▼
The current price of XMP1.MU is €3.45 EUR — it has increased by +12.38% in the past 24 hours. Watch Cerenome stock price performance more closely on the chart.
What is Cerenome stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cerenome stocks are traded under the ticker XMP1.MU.
What is Cerenome market cap?▼
Today Cerenome has the market capitalization of 26.18M
When is the next Cerenome earnings date?▼
Cerenome is going to release the next earnings report on October 15, 2026.
What were Cerenome earnings last quarter?▼
XMP1.MU earnings for the last quarter are -0.9 EUR per share, whereas the estimation was -0.73 EUR resulting in a -23.82% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cerenome revenue for the last year?▼
Cerenome revenue for the last year amounts to 4.51M EUR.
What is Cerenome net income for the last year?▼
XMP1.MU net income for the last year is -20.35M EUR.
How many employees does Cerenome have?▼
As of September 06, 2026, the company has 28 employees.
In which sector is Cerenome located?▼
Cerenome operates in the Health & Wellness sector.
When did Cerenome complete a stock split?▼
The last stock split for Cerenome was on April 02, 2026 with a ratio of 1:25.
Where is Cerenome headquartered?▼
Cerenome is headquartered in HOUSTON, United States.